This article is more than 5 years old. Information may no longer be current.

Epikeratome granted EU marketing approval

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

ATLANTA — The Centurion SES EpiEdge epikeratome has received the CE Mark from European Union regulators, according to CIBA Vision, the device’s marketer.

The EpiEdge epikeratome is used as part of the epi-LASIK refractive procedure and is compatible with the Centurion SES system. “The EpiEdge’s ability to create intact sheets of epithelium versus standard stromal cuts and its compatibility with wave front, customized ablation make it a valuable tool for refractive surgeons,” said Ioannis Pallikaris, MD, PhD, the developer of the Epi-LASIK procedure, in a press release from CIBA Vision.

The epikeratome works by performing mechanical, rather than alcohol-assisted, separation of the epithelium, substituting a disposable, oscillating PMMA block for the usual microkeratome blade, according to the press release.